BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11210742)

  • 1. [Identification and characterization of pathogenic autoreactive T cells in patients with idiopathic thrombocytopenic purpura].
    Kuwana M; Kawakami Y; Ikeda Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):555-7. PubMed ID: 11210742
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
    Kuwana M; Kaburaki J; Ikeda Y
    J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoreactive T cells involved in pathogenesis of ITP as a target for immune therapy].
    Kuwana M
    Rinsho Ketsueki; 2000 Jun; 41(6):454-7. PubMed ID: 10921340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent topics on basic research for idiopathic thrombocytopenic purpura].
    Kuwana M; Kawakami Y; Ikeda Y
    Rinsho Byori; 2001 Oct; 49(10):992-5. PubMed ID: 11769478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura.
    Kuwana M; Ikeda Y
    Int J Hematol; 2005 Feb; 81(2):106-12. PubMed ID: 15765777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epitope analysis of anti-GPIIb-IIIa autoantibodies in chronic ITP].
    Kosugi S; Tomiyama Y
    Rinsho Ketsueki; 2005 Feb; 46(2):104-8. PubMed ID: 16447703
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura.
    Kuwana M; Kawakami Y; Ikeda Y
    Blood; 2003 Jan; 101(2):621-3. PubMed ID: 12393517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparisons of antibody-binding sites of platelet glycoprotein IIb/IIIa in aplastic anemia and idiopathic thrombocytopenic purpura.
    Kahng J; Park HH; Han K; Choi BY; Lee W
    Ann Clin Lab Sci; 2008; 38(1):6-11. PubMed ID: 18316775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of chronic immune thrombocytopenic purpura.
    Cines DB; McMillan R
    Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isolation and characterisation of antiplatelet antibodies.
    Hamidpour M; Behrendt M; Griffiths B; Partridge L; Lindsey N
    Eur J Haematol; 2006 Apr; 76(4):331-8. PubMed ID: 16519705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an epitope on glycoprotein IIb-IIIa that is recognized by HLA-DRB1*0405-restricted CD4+'superior' T cells from a patient with immune thrombocytopenic purpura.
    Yamanouchi J; Hato T; Tamura T; Fujita S; Yasukawa M
    J Thromb Haemost; 2004 Feb; 2(2):348-50. PubMed ID: 14996009
    [No Abstract]   [Full Text] [Related]  

  • 12. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis.
    Kajihara M; Kato S; Okazaki Y; Kawakami Y; Ishii H; Ikeda Y; Kuwana M
    Hepatology; 2003 Jun; 37(6):1267-76. PubMed ID: 12774004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on autoimmune thrombocytopenic purpura related antibody].
    Lu L; Hou M; Shi Y; Qin P; Peng J; Zhu YY; Zhang MH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):477-9. PubMed ID: 14575592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of platelet-associate autoantibodies against platelet-specific receptors by cytometric bead array and its clinical application in idiopathic thrombocytopenic purpura].
    Liu XG; Wang YM; Hou M; Zhang T; Zhu YY; Peng J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):175-8. PubMed ID: 18788617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura.
    Kuwana M; Nomura S; Fujimura K; Nagasawa T; Muto Y; Kurata Y; Tanaka S; Ikeda Y
    Blood; 2004 Feb; 103(4):1229-36. PubMed ID: 14551140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idiopathic thrombocytopenic purpura (ITP)].
    Nomura S
    Ryoikibetsu Shokogun Shirizu; 2000; (31):181-5. PubMed ID: 11269051
    [No Abstract]   [Full Text] [Related]  

  • 17. [Idiopathic thrombocytopenic purpura in childhood].
    Miyata H
    Ryoikibetsu Shokogun Shirizu; 2000; (31):172-7. PubMed ID: 11269049
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies.
    Escher R; Vogel M; Escher G; Miescher S; Stadler BM; Berchtold P
    J Autoimmun; 2002 Feb; 18(1):71-81. PubMed ID: 11869049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antiidiotypic antibodies on the clinical course of idiopathic thrombocytopenic purpura.
    Mehta YS; Ghosh K; Badakere SS; Pathare AV; Mohanty D
    J Lab Clin Med; 2003 Aug; 142(2):113-20. PubMed ID: 12960958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura.
    Kuwana M; Okazaki Y; Satoh T; Asahi A; Kajihara M; Ikeda Y
    Am J Med; 2005 Sep; 118(9):1026-33. PubMed ID: 16164890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.